Literature DB >> 11220685

IL-4 is required for defense against mycobacterial infection.

I Sugawara1, H Yamada, S Mizuno, Y Iwakura.   

Abstract

Although the involvement of T helper (Th1) cells is central to protection against intracellular bacteria, including Mycobacterium tuberculosis, the involvement of Th2 cells, characterized by potent interleukin (IL)-4 secretion in mycobacterial infection is still unclear. In order to clarify the role of IL-4 in murine tuberculosis, IL-4-deficient mutant mice, IL-4 knockout (IL-4 KO) mice, were utilized. The mice were infected with H37Rv, Kurono or BCG Pasteur via an airborne infection route by placing them in the exposure chamber of a Middlebrook airborne infection apparatus. Their capacity to control mycobacterial growth, granuloma formation, cytokine secretion, and nitric oxide (NO) production were examined. These mice developed large granulomas, but not necrotic lesions in the lungs, liver or spleen (P<0.05). This was consistent with a significant increase in lung colony-forming units (CFU). Compared with levels in wild-type mice, upon stimulation with mycobacteria, splenic IL-10 levels were low and IL-6 levels were intermediate, but interferon (IFN)-gamma and IL-12 levels were significantly higher. IL-18 levels were within the normal range. The level of NO production by alveolar macrophages of the IL-4 KO mice was similar to that of the wild-type mice. Granulomatous lesion development by IL-4 KO mice was inhibited significantly by treatment with exogenous recombinant IL-4. These findings were not specific to the IL-4 KO mice used. Our data show that IL-4 may play a protective role in defense against mycobacteria, although IFN-gamma and TNF-alpha play major roles in it. Our data do not rule out an IFN-gamma-independent function of IL-4 in controlling tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11220685     DOI: 10.1111/j.1348-0421.2000.tb02592.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  14 in total

1.  Cytokine expression profiles of bovine lymph nodes: effects of Mycobacterium bovis infection and bacille Calmette-Guérin vaccination.

Authors:  S Widdison; L J Schreuder; B Villarreal-Ramos; C J Howard; M Watson; T J Coffey
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

Review 2.  Model for immune responses to Mycobacterium avium subspecies paratuberculosis in cattle.

Authors:  Paul M Coussens
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

3.  Adjuvant modulation of the cytokine balance in Mycobacterium tuberculosis subunit vaccines; immunity, pathology and protection.

Authors:  Else Marie Agger; Joseph P Cassidy; Joseph Brady; Karen S Korsholm; Carina Vingsbo-Lundberg; Peter Andersen
Journal:  Immunology       Date:  2008-01-12       Impact factor: 7.397

4.  Distribution of IFN-gamma, IL-4 and TNF-alpha protein and CD8 T cells producing IL-12p40 mRNA in human lung tuberculous granulomas.

Authors:  Gael Fenhalls; Liesel Stevens; Juanita Bezuidenhout; Gillian E Amphlett; Ken Duncan; Philip Bardin; Pauline T Lukey
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

5.  Immunoregulatory cytokines are associated with protection from immunopathology following Mycobacterium avium subspecies paratuberculosis infection in red deer.

Authors:  M W Robinson; R O'Brien; C G Mackintosh; R G Clark; J F T Griffin
Journal:  Infect Immun       Date:  2011-02-14       Impact factor: 3.441

Review 6.  Innate immunity to Mycobacterium tuberculosis.

Authors:  Reinout van Crevel; Tom H M Ottenhoff; Jos W M van der Meer
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

7.  Evaluation of T cell immune responses in multi-drug-resistant tuberculosis (MDR-TB) patients to Mycobacterium tuberculosis total lipid antigens.

Authors:  A S Shahemabadi; A Zavaran Hosseini; S Shaghsempour; M R Masjedi; M Rayani; M Pouramiri
Journal:  Clin Exp Immunol       Date:  2007-05-09       Impact factor: 4.330

8.  Differential expression of interleukin-4 (IL-4) and IL-4 delta 2 mRNA, but not transforming growth factor beta (TGF-beta), TGF-beta RII, Foxp3, gamma interferon, T-bet, or GATA-3 mRNA, in patients with fast and slow responses to antituberculosis treatment.

Authors:  Joel Fleury Djoba Siawaya; Nchinya Bennedict Bapela; Katharina Ronacher; Nulda Beyers; Paul van Helden; Gerhard Walzl
Journal:  Clin Vaccine Immunol       Date:  2008-06-25

9.  Overexpression of interleukin-4 in lungs of mice impairs elimination of Histoplasma capsulatum.

Authors:  Lucy A Gildea; Reta Gibbons; Fred D Finkelman; George S Deepe
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

10.  Dual role of interleukin-4 (IL-4) in pulmonary paracoccidioidomycosis: endogenous IL-4 can induce protection or exacerbation of disease depending on the host genetic pattern.

Authors:  Celina Arruda; Rita C Valente-Ferreira; Adriana Pina; Suely S Kashino; Raquel A Fazioli; Celidéia A C Vaz; Marcello F Franco; Alexandre C Keller; Vera L G Calich
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.